fbpx

Good news for families with life-threatening allergies

The U.S. Food and Drug Administration recently approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds. Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.

Life-threatening allergies can include reactions to insect bites or stings, foods, medications, latex or other causes. Anaphylaxis is a medical emergency that affects the whole body and, in some cases, leads to death. Anaphylaxis occurs in approximately one in 50 Americans. People who have had an anaphylaxis episode always face the risk of another one. Because of this risk, they must carry an emergency dose of epinephrine. Many must keep more than one dose at hand. This epinephrine injection (auto-injector) is intended for immediate administration to patients. When given intramuscularly or subcutaneously, it has a rapid onset and short duration of action. Epinephrine works by reducing swelling in the airway and increasing blood flow in the veins.

SHARE THIS
Share on facebook
Share on twitter
Share on google
Share on pinterest
YOU MAY ALSO LIKE
LEAVE A COMMENT

Leave a Reply

Sign Up For Our Newsletter.

Stay connected for your daily dose of Parenting Advice, Houston Area Events, Awesome Giveaways and much more!

Thanks for joining our family.

Blue Willow Oct
Houston Family Download App Button

october, 2020

X
X